GENOME THERAPEUTICS LTD
Research and experimental development on biotechnology
GENOME THERAPEUTICS LTD
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Regent House 316 Beulah Hill London SE19 3HF United Kingdom
Full company profile for GENOME THERAPEUTICS LTD (12392992), an active company based in London, United Kingdom. Incorporated 8 Jan 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2021–2025)
Cash in Bank
£362.94k
Net Assets
£364.83k
Total Liabilities
£278.02k
Turnover
N/A
Employees
6
Debt Ratio
43%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 30 Jun Year End | 2024 30 Jun Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Bobby Satyadev Yerramilli-rao | Director | British | United Kingdom | 6 Jun 2024 | Active |
| Shankar Balasubramanian | Director | British,indian | England | 8 Jan 2020 | Active |
See all 9 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Samuel Aparicio
Canadian
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Sir Shankar Balasubramanian
British,indian
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent
Samuel Aparicio
Ceased 18 Oct 2024
Bobby Satyadev Yerramilli-rao
Ceased 29 Jan 2020
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 21 Jan 2026 | Confirmation Statement | Confirmation statement made on 7 Jan 2026 with updates | |
| 20 Jan 2026 | Officers | Change to director Mr Dan Mchugh on 20 Jan 2026 | |
| 18 Dec 2025 | Incorporation | Memorandum Articles | |
| 18 Dec 2025 | Resolution | Resolutions | |
| 11 Dec 2025 | Capital | Allotment of shares (GBP 196.2593) on 26 Nov 2025 |
Confirmation statement made on 7 Jan 2026 with updates
Change to director Mr Dan Mchugh on 20 Jan 2026
Memorandum Articles
Resolutions
Allotment of shares (GBP 196.2593) on 26 Nov 2025
Recent Activity
Latest Activity
Confirmation statement made on 7 Jan 2026 with updates
4 months ago on 21 Jan 2026
Change to director Mr Dan Mchugh on 20 Jan 2026
4 months ago on 20 Jan 2026
Memorandum Articles
5 months ago on 18 Dec 2025
Resolutions
5 months ago on 18 Dec 2025
Allotment of shares (GBP 196.2593) on 26 Nov 2025
5 months ago on 11 Dec 2025